beta-lactams has been researched along with gemfibrozil in 1 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (gemfibrozil) | Trials (gemfibrozil) | Recent Studies (post-2010) (gemfibrozil) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 1,483 | 359 | 297 |
| Protein | Taxonomy | beta-lactams (IC50) | gemfibrozil (IC50) |
|---|---|---|---|
| Cytochrome P450 2C8 | Homo sapiens (human) | 4.1 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 7.0795 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 4.0738 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, N; Dwivedi, J; Jagdale, AY; Jain, KS; Munde, MK | 1 |
1 other study(ies) available for beta-lactams and gemfibrozil
| Article | Year |
|---|---|
Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones.
Topics: Animals; Azetidines; Biomarkers; Cholesterol; Disease Models, Animal; Drug Design; Gemfibrozil; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Intestinal Mucosa; Intestines; Molecular Structure; Polyethylene Glycols; Pyrimidinones; Rats; Rats, Wistar; Structure-Activity Relationship; Triglycerides | 2013 |